Cargando…
Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity
SIMPLE SUMMARY: The application of immunotherapies to treat cancer patients has significantly improved over the last two decades and extended many patients’ life spans. Monoclonal antibodies are synthetic proteins employed as immunotherapies to treat and manage cancers that require a complete unders...
Autores principales: | Kumar, Mohit, Thangavel, Chellappagounder, Becker, Richard C., Sadayappan, Sakthivel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795565/ https://www.ncbi.nlm.nih.gov/pubmed/33396766 http://dx.doi.org/10.3390/cancers13010086 |
Ejemplares similares
-
CDK4/6 inhibition protects normal cells against cancer therapy-induced damage
por: Boopathi, Ettickan, et al.
Publicado: (2020) -
Dark Side of Cancer Therapy: Cancer Treatment-Induced Cardiopulmonary Inflammation, Fibrosis, and Immune Modulation
por: Boopathi, Ettickan, et al.
Publicado: (2021) -
Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium
por: Lynch, Thomas L, et al.
Publicado: (2014) -
Modulation of myosin by cardiac myosin binding protein-C peptides improves cardiac contractility in ex-vivo experimental heart failure models
por: Hou, Luqia, et al.
Publicado: (2022) -
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016)